ADMA vs. CRDO

Last updated Jun 13, 2026

ADMA (ADMA Biologics, Inc.) and CRDO (Credo Technology Group Holding Ltd) are both stocks. ADMA operates in Biotechnology (Healthcare), while CRDO operates in Semiconductors (Technology). Over the past 3 years, ADMA returned 27.09%/yr vs 142.90%/yr for CRDO. At a 0.27 correlation, their price movements are largely independent.

Performance

ADMA vs. CRDO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ADMA Biologics, Inc. (ADMA) and Credo Technology Group Holding Ltd (CRDO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ADMA achieves a -54.99% return, which is significantly lower than CRDO's 74.31% return.

ADMA

• 1D: -1.32%
• 1M: -3.41%
• YTD: -54.99%
• 6M: -58.49%
• 1Y: -61.99%
• 3Y*: 27.09%
• 5Y*: 35.16%
• 10Y*: 1.84%

CRDO

• 1D: -5.27%
• 1M: 32.45%
• YTD: 74.31%
• 6M: 74.28%
• 1Y: 237.38%
• 3Y*: 142.90%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ADMA vs. CRDO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
ADMA ADMA Biologics, Inc.	-54.99%	6.36%	279.42%	16.49%	173.24%
CRDO Credo Technology Group Holding Ltd	74.31%	114.09%	245.20%	46.28%	10.00%

Correlation

The correlation between ADMA and CRDO is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.14
Correlation (3Y) Calculated over the trailing 3-year period	0.27
Correlation (All Time) Calculated using the full available price history since Jan 27, 2022	0.27

The correlation between ADMA and CRDO shifts across timeframes, from 0.14 (1 year) to 0.27 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap ADMA : $1.97B CRDO : $48.33B
EPS ADMA : $0.68 CRDO : $2.50
PE Ratio ADMA : 12.13 CRDO : 100.50
PS Ratio ADMA : 3.93 CRDO : 35.55
PB Ratio ADMA : 5.05 CRDO : 23.42
Total Revenue (TTM) ADMA : $509.86M CRDO : $1.34B
Gross Profit (TTM) ADMA : $312.42M CRDO : $908.35M
EBITDA (TTM) ADMA : $218.74M CRDO : $463.79M

Return for Risk

ADMA vs. CRDO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ADMA

ADMA Risk / Return Rank: 3
ADMA Sharpe Ratio Rank: 3
ADMA Sortino Ratio Rank: 4
ADMA Omega Ratio Rank: 4
ADMA Calmar Ratio Rank: 3
ADMA Martin Ratio Rank: 1

CRDO

CRDO Risk / Return Rank: 90
CRDO Sharpe Ratio Rank: 95
CRDO Sortino Ratio Rank: 89
CRDO Omega Ratio Rank: 86
CRDO Calmar Ratio Rank: 91
CRDO Martin Ratio Rank: 89

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ADMA vs. CRDO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ADMA Biologics, Inc. (ADMA) and Credo Technology Group Holding Ltd (CRDO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ADMA	CRDO	Difference
Sharpe ratio: Return per unit of total volatility	-1.14	2.79	-3.93
Sortino ratio: Return per unit of downside risk	-1.82	2.95	-4.76
Omega ratio: Gain probability vs. loss probability	0.76	1.35	-0.59
Calmar ratio: Return relative to maximum drawdown	-0.98	4.46	-5.44
Martin ratio: Return relative to average drawdown	-1.95	10.76	-12.71

ADMA vs. CRDO - Sharpe Ratio Comparison

The current ADMA Sharpe Ratio is -1.14, which is lower than the CRDO Sharpe Ratio of 2.79. The chart below compares the historical Sharpe Ratios of ADMA and CRDO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ADMA vs. CRDO - Drawdown Comparison

The maximum ADMA drawdown since its inception was -91.28%, which is greater than CRDO's maximum drawdown of -62.04%. Use the drawdown chart below to compare losses from any high point for ADMA and CRDO.

Drawdown Indicators

	ADMA	CRDO	Difference
Max Drawdown Largest peak-to-trough decline	-91.28%	-62.04%	-29.24%
Max Drawdown (1Y) Largest decline over 1 year	-63.48%	-53.59%	-9.89%
Max Drawdown (3Y) Largest decline over 3 years	-68.99%	-61.05%	-7.94%
Max Drawdown (5Y) Largest decline over 5 years	-68.99%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-86.11%	—	—
Current Drawdown Current decline from peak	-66.50%	-5.27%	-61.23%
Average Drawdown Average peak-to-trough decline	-53.05%	-19.38%	-33.67%
Ulcer Index Depth and duration of drawdowns from previous peaks	33.85%	22.17%	+11.68%

Volatility

ADMA vs. CRDO - Volatility Comparison

The current volatility for ADMA Biologics, Inc. (ADMA) is 9.74%, while Credo Technology Group Holding Ltd (CRDO) has a volatility of 28.41%. This indicates that ADMA experiences smaller price fluctuations and is considered to be less risky than CRDO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ADMA	CRDO	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.74%	28.41%	-18.67%
Volatility (6M) Calculated over the trailing 6-month period	45.54%	65.16%	-19.62%
Volatility (1Y) Calculated over the trailing 1-year period	54.60%	85.70%	-31.10%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	59.47%	81.50%	-22.03%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	69.03%	81.50%	-12.47%

Dividends

ADMA vs. CRDO - Dividend Comparison

Neither ADMA nor CRDO has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

ADMA vs. CRDO - Profitability Comparison

The chart below illustrates the profitability comparison between ADMA Biologics, Inc. and Credo Technology Group Holding Ltd over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

ADMA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported a gross profit of 80.75M and revenue of 114.49M. Therefore, the gross margin over that period was 70.5%.

CRDO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Credo Technology Group Holding Ltd reported a gross profit of 298.07M and revenue of 437.00M. Therefore, the gross margin over that period was 68.2%.

ADMA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported an operating income of 58.27M and revenue of 114.49M, resulting in an operating margin of 50.9%.

CRDO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Credo Technology Group Holding Ltd reported an operating income of 155.85M and revenue of 437.00M, resulting in an operating margin of 35.7%.

ADMA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported a net income of 45.33M and revenue of 114.49M, resulting in a net margin of 39.6%.

CRDO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Credo Technology Group Holding Ltd reported a net income of 169.10M and revenue of 437.00M, resulting in a net margin of 38.7%.

Frequently Asked Questions

Can I hold both ADMA and CRDO in my portfolio?

ADMA and CRDO have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ADMA or CRDO?

CRDO has higher volatility (28.41%) compared to ADMA (9.74%). In terms of maximum drawdown, ADMA dropped -91.28% vs CRDO's -62.04%.

Which has better risk-adjusted returns?

CRDO currently has the higher Sharpe Ratio (2.79 vs -1.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.